Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Fat-Produced Adipsin Regulates Inflammatory Arthritis.

Yongjia Li | Wei Zou | Jonathan R Brestoff | Nidhi Rohatgi | Xiaobo Wu | John P Atkinson | Charles A Harris | Steven L Teitelbaum
Cell reports | 2019

We explored the relationship of obesity and inflammatory arthritis (IA) by selectively expressing diphtheria toxin in adipose tissue yielding "fat-free" (FF) mice completely lacking white and brown fat. FF mice exhibit systemic neutrophilia and elevated serum acute phase proteins suggesting a predisposition to severe IA. Surprisingly, FF mice are resistant to K/BxN serum-induced IA and attendant bone destruction. Despite robust systemic basal neutrophilia, neutrophil infiltration into joints of FF mice does not occur when challenged with K/BxN serum. Absence of adiponectin, leptin, or both has no effect on joint disease, but deletion of the adipokine adipsin (complement factor D) completely prevents serum-induced IA. Confirming that fat-expressed adipsin modulates the disorder, transplantation of wild-type (WT) adipose tissue into FF mice restores susceptibility to IA, whereas recipients of adipsin-deficient fat remain resistant. Thus, adipose tissue regulates development of IA through a pathway in which adipocytes modify neutrophil responses in distant tissues by producing adipsin.

Pubmed ID: 31167128

Associated grants

  • Agency: NIAMS NIH HHS, United States
    Id: P30 AR057235
  • Agency: NIAMS NIH HHS, United States
    Id: R37 AR046523
  • Agency: NIAMS NIH HHS, United States
    Id: P30 AR073752
  • Agency: NIAMS NIH HHS, United States
    Id: P30 AR074992
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK056341
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM099111
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK111389
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK106083

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


PRISM (tool)

RRID:SCR_005375

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on May 5,2022.Tool that predicts interactions between transcription factors and their regulated genes from binding motifs. Understanding vertebrate development requires unraveling the cis-regulatory architecture of gene regulation. PRISM provides accurate genome-wide computational predictions of transcription factor binding sites for the human and mouse genomes, and integrates the predictions with GREAT to provide functional biological context. Together, accurate computational binding site prediction and GREAT produce for each transcription factor: 1. putative binding sites, 2. putative target genes, 3. putative biological roles of the transcription factor, and 4. putative cis-regulatory elements through which the factor regulates each target in each functional role.

View all literature mentions

PE/Cyanine7 anti-mouse Ly-6G (antibody)

RRID:AB_1877262

This monoclonal targets Ly-6G

View all literature mentions

APC anti-mouse F4/80 (antibody)

RRID:AB_893493

This monoclonal targets F4/80

View all literature mentions

FITC anti-mouse Ly-6C (antibody)

RRID:AB_1186134

This monoclonal targets Ly-6C

View all literature mentions

Anti-Tau, Caspase Cleaved (truncated at Asp421) (antibody)

RRID:AB_210837

This monoclonal targets Tau, Caspase Cleaved (truncated at Asp421)

View all literature mentions